Variables Histology | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | |
Jaundice | 7.76 | (0.93–65.12) | 0.06 | 11.85 | (1.17–119.79) | 0.04 |
Benign (1–1.5%) | ||||||
Malignant (7–11%) | ||||||
Acute pancreatitis | 1.23 | (0.50–3.01) | 0.65 | – | ||
Benign (11–18%) | ||||||
Malignant (13–21%) | ||||||
New onset of diabetes | 0.31 | (0.06–1.61) | 0.16 | 0.17 | (0.03–1.09) | 0.06 |
Benign (7–11%) | ||||||
Malignant (2–3%) | ||||||
Cyst ≥4 cm | 4.87 | (2.10–11.30) | 0.0002 | 5.61 | (2.02–15.5) | < 0.001 |
Benign (6–10%) | ||||||
Malignant (26–42%) | ||||||
Cyst ≥3 cm (*) | 2.82 | (1.34–5.96) | 0.007 | 2.78 | (1.80–6.54) | 0.02 |
Benign (30–48%) | ||||||
Malignant (45–72.5%) | ||||||
MD size 5–9.9 mm | 2.24 | (1.08–4.64) | 0.03 | 4.77 | (1.78–12.77) | 0.002 |
Benign (20–38.5%) | ||||||
Malignant (32–51.5%) | ||||||
MD size ≥10 mm | 2.55 | (1.15–5.64) | 0.02 | 7.52 | (2.47–22.89) | 0.0004 |
Benign (13–21%) | ||||||
Malignant (25–40%) | ||||||
Solid component | 1.90 | (0.81–4.45) | 0.14 | 1.86 | (0.67–5.20) | 0.24 |
Benign (11–18%) | ||||||
Malignant (18–29%) | ||||||
Enhanced mural nodule > 5 mm | 1.13 | (0.43–3.01) | 0.80 | – | ||
Benign (9–14.5%) | ||||||
Malignant (10–16%) | ||||||
Rapid progression | 0.75 | (0.26–2.16) | 0.59 | – | ||
Benign (9–14.5%) | ||||||
Malignant (7–1%) |